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Ambient levels of particulate matter have been linked to cardiovascular disease. The mechanisms mediating
these associations are poorly understood. One candidate mechanism is inflammation. Using data from the Multi-
Ethnic Study of Atherosclerosis (2000–2002), the authors investigated the relation between exposure to particulate
matter of less than or equal to 2.5 lm in diameter (PM2.5) and C-reactive protein concentration in 5,634 persons
aged 45–84 years who were free of cardiovascular disease. Data from US Environmental Protection Agency
monitors were used to estimate PM2.5 exposures for the prior day, prior 2 days, prior week, prior 30 days, and
prior 60 days. Only the 30-day and 60-day mean exposures showed a weak positive association with C-reactive
protein, and confidence intervals were wide: relative increases in C-reactive protein per 10 lg/m3 of PM2.5 adjusted
for person-level covariates were 3% (95% confidence interval (CI): –2, 10) for a 30-day mean and 4% (95%
CI: –3, 11.0) for a 60-day mean. The means of 7-day, 30-day, and 60-day exposures were weakly, positively,
and nonsignificantly associated with the odds of C-reactive protein of greater than or equal to 3 mg/liter: adjusted
odds ratios were 1.05 (95% CI: 0.96, 1.15), 1.12 (95% CI: 0.98, 1.29), and 1.12 (95% CI: 0.96, 1.32), respectively.
Slightly stronger associations were observed in persons without other risk factors for elevated C-reactive protein,
but this heterogeneity was not statistically significant. The authors’ results are not compatible with strong effects of
particulate matter exposures on population levels of C-reactive protein.
air pollutants, environmental; cardiovascular diseases; inflammation
Abbreviations: CI, confidence interval; MESA, Multi-Ethnic Study of Atherosclerosis; PM2.5, particulate matter of less than or
equal to 2.5 lm in diameter; PM10, particulate matter of less than or equal to 10 lm in diameter.
A growing body of work has linked ambient levels of
particulate matter to cardiovascular disease morbidity and
mortality (1–6), but the mechanisms mediating these asso-
ciations are still poorly understood. One of several plausible
biologic mechanisms linking particulate matter exposure to
cardiovascular risk is increased inflammation (7–9). It has
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been postulated that the interaction of alveolar macrophages
with atmospheric particles results in increased oxidant pro-
duction and the release of inflammatory mediators (10),
which may in turn participate in the development of athero-
sclerotic disease or the precipitation of clinical events in
persons with underlying disease (11). Ultrafine particles
may also exert systemic effects through direct passage of
particles into the blood circulation (12).
Experimental evidence from animal and human studies
has shown that exposure to inhaled particles is associated
with local inflammatory changes in the lung and may result
in a systemic inflammatory response (13–18). However,
there is still limited evidence on the extent to which exposure
to particulate matter is associated with changes in levels of
systemic inflammatory markers in the general population.
Although two epidemiologic studies have reported positive
associations between recent exposures to particles and
markers of the acute phase response such as C-reactive pro-
tein and fibrinogen (19, 20), other studies have reported as-
sociations limited to the summer months (21), associations
present for ambient exposures but not personal exposure
(22), positive associations that disappear when highly influ-
ential observations are excluded (23), and even negative
associations (22).
Most prior studies of exposure to particles and inflamma-
tory markers have investigated relatively short lags, ranging
from exposures the same day to exposures during the 5 prior
days. However, it is plausible that repeated exposures have
effects that accumulate over time. The presence of cumula-
tive effects is consistent with recent work showing that ex-
posures occurring more remotely (in some cases during the
prior 1–2 months) are associated with all-cause and cardio-
vascular mortality in time series analyses (24–26), although
results regarding the effects of recent and long-term expo-
sures on cardiovascular mortality have not always been con-
sistent (27). No studies have investigated long-term exposures
in relation to C-reactive protein levels in population-based
samples.
Using data from a large, multiethnic, population-based
study of atherosclerosis, we investigated the relation between
recent exposure to particulate matter of less than or equal
to 2.5 lm in diameter (PM2.5) and levels of inflammatory
markers. We hypothesized that recent exposure to PM2.5
would be positively associated with higher C-reactive pro-
tein concentration, after adjustment for potential confound-
ers. We also investigated lags ranging from the prior day to
the prior 2 months. The confirmation of a relation between
air particulate exposure and markers of systemic inflamma-
tion would lend support for a mechanistic pathway linking
air pollution to cardiovascular disease, and it would also
suggest that exposure to particulate matter may be etiologi-
cally relevant to other diseases processes in which inflam-
mation may play a causal role.
MATERIALS AND METHODS
Subjects
The Multi-Ethnic Study of Atherosclerosis (MESA) (28)
is a longitudinal study supported by the National Heart,
Lung, and Blood Institute with the overall goal of identify-
ing risk factors for subclinical atherosclerosis. A total of
6,814 men and women, who identified themselves as White,
Black, Hispanic, or Chinese and were aged 45–84 years and
free of clinically apparent cardiovascular disease, were re-
cruited from portions of six US communities: Baltimore
City and Baltimore County, Maryland; Chicago, Illinois;
Forsyth County, North Carolina; Los Angeles County, Cal-
ifornia; northern Manhattan and the Bronx, New York; and
St. Paul, Minnesota. Each site recruited by randomly select-
ing potential participants from locally available sources
(lists of residents or dwellings) or using random digit di-
aling. Details of the sampling plan have been previously
reported (28). Among those screened and deemed eligible,
the participation rate was 59.8 percent. The baseline visit for
the cohort (on which these analyses are based) took place
between June 2000 and August 2002.
Measurements and variable definitions
Pollutant data were extracted from the US Environmental
Protection Agency’s Aerometric Information Retrieval Sys-
tem (AIRS) in November 2003 (29). PM2.5 concentrations
were obtained from 24-hour samples, some of which col-
lected data daily, but most of which collected data every
third day. For each person, we constructed a set of cumula-
tive exposure measures for the 60 days prior to the day on
which blood was drawn. Each daily exposure was based on
the monitor nearest to the person’s residence with available
data on that day. This ensured that complete data were avail-
able for most participants but, because most monitors col-
lected data every third day, the monitor from which data
were drawn could differ for different days. The mean dis-
tance to the nearest monitor was 9 km (distance ranged from
0.45 to 51 km). Five exposure measures were constructed by
use of the 60-day lags: prior day, average of prior 2 days,
average of prior week, average of prior month, and average
of prior 2 months.
C-reactive protein was measured in all participants at
baseline using a Behring nephelometer II (BNII) automated
immunoanalyzer (N High Sensitivity CRP assay; Dade
Behring, Inc., Deerfield, Illinois) at the Laboratory for Clinical
Biochemistry Research (University of Vermont, Burlington,
Vermont). Site and central laboratory quality control proce-
dures are reported elsewhere (28). Intraassay coefficients of
variation range from 2.3 to 4.4 percent, and interassay coef-
ficients of variation range from 2.1 to 5.7 percent. C-reactive
protein values were highly skewed and were log transformed
for analyses. Individual-level variables known to be associ-
ated with C-reactive protein concentrations that could also
covary with day of visit (and hence with particulate matter
levels) were examined as covariates (refer to table 1 for list).
Because PM2.5 concentrations vary by site and site could be
associated with C-reactive protein concentrations through
other mechanisms, results are also shown after additional
adjustment for site. Selected analyses were also repeated for
interleukin-6, another inflammatory marker. Interleukin-6
was measured by an ultrasensitive enzyme-linked immuno-
sorbent assay (Quantikine HS human interleukin-6 immuno-
assay; R&D Systems, Minneapolis, Minnesota).
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Other gaseous pollutants (sulfur dioxide, nitrogen dioxide,
carbon monoxide, and ozone) and weather variables (temper-
ature and dew point temperature) were included as covariates
in some models because of their association with PM2.5 and
their potential effects on C-reactive protein concentrations.
Nitrogen dioxide and sulfur dioxide daily averages were
computed by averaging hourly data if at least 20 hours of
data were recorded for a 24-hour period. Ozone and carbon
monoxide were represented by the maximum 8-hour running
average for a 24-hour period. Measures of daily average
temperature, dew point temperature, and sea level barometric
pressure were obtained from a National Weather Service
monitoring station that was representative of each study area.
Cumulative exposures for copollutants and weather repli-
cated the lagged averaging scheme described for PM2.5.
Data analysis
Scatterplots, LOESS smoothing by SAS/STAT software
(SAS Institute, Inc., Cary, North Carolina), and generalized
additive models (30) were initially used to investigate the
shape of the relation between each of our five measures of
exposure and log C-reactive protein concentration. Linear
regression was then used to estimate the associations of
PM2.5 exposures with C-reactive protein concentration be-
fore and after adjustment for the individual-level covariates,
study site, copollutants, and weather. The presence of sea-
sonal trends was investigated by examining seasonal pat-
terns in the residuals of fully adjusted models. We tested
for the presence of residual autocorrelation using the Durbin-
Watson d statistic.
TABLE 1. Demographic characteristics, exposure to
particulate matter of 2.5 mm in diameter, and C-reactive
protein concentrations for the 5,634 participants included in the
analyses, Multi-Ethnic Study of Atherosclerosis, 2000–2002







Study site (% distribution)
Baltimore, MD 15.7
Chicago, IL 18.1
Forsyth County, NC 15.7
Los Angeles, CA 19.0
New York City, NY 16.0
St. Paul, MN 15.5






Body mass index, kg/m2 (mean (SD)) 28.25 (5.37)
Diabetes (% distribution)y
No 58.5
Impaired glucose tolerance 28.1
Diabetes 13.5




Secondhand smoke (% distribution)z
None 53.0








% with arthritis flare within past 2 weeks{ 12.2
% with regular use of any nonsteroidal
antiinflammatory drugs, aspirin,
or lipid-lowering medications{ 45.4
% with infections within past 2 weeks{ 23.2
PM2.5,* lg/m
3 (median (25th, 75th
percentiles))
Prior day 14.30 (9.50, 20.90)
Prior 2 days# 14.40 (10.15, 20.35)
Prior 7 days# 15.24 (12.07, 19.70)
Prior 30 days# 15.69 (13.07, 19.22)
Prior 60 days# 15.90 (13.77, 19.08)
C-reactive protein, mg/liter
(median (25th, 75th percentiles)) 1.84 (0.82, 4.10)
* SD, standard deviation; PM2.5, particulate matter of less than or
equal to 2.5 lm in diameter.
y American Diabetes Association 2003 criteria: ‘‘impaired’’ is fast-
ing glucose of 100–125 mg/dl; ‘‘diabetic’’ is fasting glucose of 126
mg/dl or takes insulin or oral diabetes medication.
z Asked of only noncurrent smokers. Noncurrent smokers missing
secondhand smoke information (n ¼ 144) were assigned to no sec-
ondhand smoke.
§ Physical activity was based on total minutes per day and
categorized into three levels with the lowest level being the lowest
quartile, the middle level being the 25th–75th percentiles, and the
highest level being the highest quartile.
{ Persons missing arthritis, medication, or infection information
(n ¼ 5, n ¼ 21, or n ¼ 6, respectively) were assigned to no arthritis, no
medication, or no infection, respectively. ‘‘Infection’’ was definedascold,
flu, bronchitis, sinus infection, tooth infection, or urinary tract infection.
# Sample sizes for exposures were smaller than for the full sam-
ple because of missing data; n ¼ 5,606, 5,510, 5,294, and 5,136 for
the prior 2 days, prior 7 days, prior 30 days, and prior 60 days,
respectively.
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Stratified analyses were conducted to investigate if effects
differed across site, season (warmer months vs. cooler
months), or individual-level variables (age, sex, race/ethnic-
ity, education, self-reported health, diabetes, infection,
medication use, and history of asthma, bronchitis, or em-
physema). Additive interactions in the log scale (or effect
measure modification for relative differences) were tested
by including interaction terms in regression models. In order
to examine if PM2.5 exposure was related to C-reactive pro-
tein only among persons without other factors strongly
related to inflammation, we also repeated the analyses, ex-
cluding persons with any of the following characteristics/
conditions: self-reported fair/poor health, impaired glucose
tolerance or diabetes, current cigarette smoking, recent ar-
thritis flare, taking antiinflammatory or lipid-lowering med-
ications, or recent infection.
We examined the sensitivity of results to alternate ways of
estimating exposure by 1) restricting analyses to partici-
pants with monitors within 9 km of their home (9 km being
the mean distance in our sample) and 2) using the average of
all available monitors within the city of residence (defined
as 40 km or 25 miles from the centroid of participant resi-
dences) as the exposure measure instead of the nearest mon-
itor. In additional sensitivity analyses for a subset of the
data, we compared results using the nearest monitor with
results obtained by estimating exposure at each residence
using inverse distance interpolation and space-time kriging
with a separable covariance model (31, 32). These sensitiv-
ity analyses were conducted for the site with the greatest
within-site variability in exposure (Los Angeles). In second-
ary analyses, selected (logistic) models were also run using
C-reactive protein of greater than or equal to 3 mg/liter
(the cutoff used to define high-risk groups on the basis of
C-reactive protein concentration) (33) as a binary outcome.
Of the 6,814 participants who completed the baseline
examination, 6,069 participated in the air pollution study.
Of these, 147 were excluded because latitude and longitude
coordinates for their address were unavailable, 26 partici-
pants were excluded because of missing data on prior day
PM2.5 exposure, and 262 participants were excluded be-
cause of missing data on C-reactive protein or key covari-
ates of interest, yielding a total of 5,634 participants (83
percent of the total cohort) for analysis. Analyses of long-
term exposures excluded additional participants because of
missing exposure data.
RESULTS
The mean participant was 62 years of age, and 53 percent
were female. Additional characteristics of the study sample
are shown in table 1. The median PM2.5 for the set of cu-
mulative exposures investigated ranged from 14.3 lg/m3
for prior day to 15.9 lg/m3 for prior 60 days. The median
C-reactive protein level was 1.84 mg/liter. Approximately
35 percent of participants had C-reactive protein concen-
trations of greater than or equal to 3 mg/liter. Median prior
day PM2.5 exposure levels were lowest in St. Paul (10.6
lg/m3) and highest in Los Angeles (18.3 lg/m3) (figure 1).
A similar pattern was observed for the mean of the prior
60 days (not shown). Correlations between prior day expo-
sure and other exposures were 0.91, 0.60, 0.43, and 0.36 for
prior 2 days, prior 7 days, prior 30 days, and prior 60 days,
respectively (all p < 0.001). Other pairwise correlations
between exposures lay between this range. Virtually all
(99 percent) participants were within 40 km of the centroid
for the site. Of the total variance in PM2.5 measures, the
majority (74–87 percent depending on the site) were
FIGURE 1. Distribution of particulate matter of 2.5 lm in diameter (PM2.5) by study site, Multi-Ethnic Study of Atherosclerosis, 2000–2002.
Boxes represent the 25th percentile, median, and 75th percentile; box plot whiskers represent the 5th–95th percentiles.
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between days (within season), and only a small proportion
(7–19 percent) were between monitors within days.
C-reactive protein concentrations were positively associ-
ated with age, female gender, Hispanic ethnicity, body mass
index, diabetes, current smoking status, secondhand smoke,
infections, and living in Forsyth County (table 2). Self-
reported health, physical activity, and arthritis flare were also
associated with C-reactive protein in the expected direction,
although differences were not statistically significant. In
unadjusted bivariate analyses, there was no evidence of
an association between PM2.5 levels and C-reactive protein
concentration. Analyses using generalized additive models
(with adjustment for person-level covariates) also revealed
no evidence of a clear threshold for the effect of PM2.5 on
C-reactive protein for any of the exposures studied for the
range of PM2.5 levels within which the majority of study
participants were found (data available from authors upon
request).
Table 3 shows relative differences in C-reactive protein
per 10-lg/m3 increase in PM2.5 for the range of models
fitted. Overall, there was no clear evidence of a positive
association between PM2.5 exposure and C-reactive protein
concentration for any of the exposures studied. PM2.5 levels
for the prior day, prior 2 days, and prior 7 days were not
positively associated with C-reactive protein. In models
adjusted for person-level covariates, only the 30-day and
60-day exposures (in some models) showed a positive
association with C-reactive protein, but differences were
small and all confidence intervals included the null value.
Compared with models adjusted for only person-level cova-
riates, site, copollutant, and weather adjustment resulted in
associations that were slightly more negative (for prior day,
prior 2 days, and prior week) or closer to the null (for prior
30 and 60 days) (table 3). Sensitivity analyses using the
study site average as the exposure and restricting the sample
to persons within 9 km of a monitor (the mean distance to
a monitor in our sample) (table 3) revealed generally similar
results. In Los Angeles (the site with the greatest within-site
variability in PM2.5), results obtained using inverse distance
interpolation and space-time kriging were very similar to
those obtained using the nearest monitor for all lags studied
(not shown). Plots of residuals from adjusted models against
time/season showed no clear evidence of seasonal or time
trends. Durbin-Watson d statistics did not indicate the pres-
ence of first-order autocorrelation. No consistent associa-
tions between particulate matter exposure and C-reactive
protein concentrations were observed when selected models
for continuous C-reactive protein were repeated for expo-
sures to particulate matter of less than or equal to 10 lm in
diameter (PM10) (not shown).
Figure 2 shows the relative difference in C-reactive pro-
tein per 10-lg/m3 difference in prior day PM2.5 for the re-
stricted sample (participants without other risk factors for
elevated C-reactive protein) compared with that of all other
participants. Although point estimates suggested weakly
positive associations with C-reactive protein in the restricted
sample for 30- and 60-day mean exposures, tests for inter-
action were not statistically significant. Of all the other in-
teractions tested (PM2.5 with age, sex, education, diabetes,
smoking, use of medications, history of infection, or history
TABLE 2. Adjusted* relative difference in C-reactive protein
(mg/liter) for the 5,634 participants included in the analyses,





Age (per 10 years) 1.09 1.05, 1.12
Gender
Female vs. male 1.54 1.46, 1.63
Race
Caucasian Referent
Chinese 0.72 0.64, 0.8
African American 1.04 0.97, 1.12
Hispanic 1.14 1.04, 1.24
Study site
Chicago, IL Referent
Baltimore, MD 1.01 0.92, 1.11
Forsyth County, NC 1.19 1.08, 1.30
Los Angeles, CA 1.09 0.99, 1.21
New York City, NY 0.91 0.82, 1.00
St. Paul, MN 1.05 0.95, 1.16
Self-reported health
Poor 1.41 0.98, 2.02
Fair 1.13 1.00, 1.27
Good 1.08 0.99, 1.17
Very good 1.04 0.96, 1.13
Excellent Referent
Body mass index (per kg/m2) 1.08 1.07, 1.09
Diabetes
No Referent
Impaired glucose tolerance 1.09 1.02, 1.16
Diabetic 1.05 0.97, 1.15
Smoking status
Never Referent
Former 1.05 0.99, 1.11
Current 1.42 1.30, 1.55
Secondhand smoke
None Referent
Any 1.09 1.03, 1.15
Physical activity
Low Referent
Medium 0.94 0.88, 1.01
High 0.93 0.86, 1.01
Arthritis
Flare vs. no flare 1.05 0.96, 1.14
Medicationsy
Use vs. no use 0.91 0.86, 0.96
Infections in past 2 weeksy
Yes vs. no 1.21 1.13, 1.28
* Each estimate is adjusted for all the other variables in the table.
The relative difference indicates the percent increase in mean
C-reactive protein associated with the variable in question. For ex-
ample, a relative difference of 1.5 indicates that C-reactive protein is
50% higher in the exposed than in the unexposed group.
yPersons missing medication or infection information (n ¼ 21 or
n ¼ 6, respectively) were assigned to no medication or no infection,
respectively. ‘‘Infection’’ was defined as cold, flu, bronchitis, sinus
infection, tooth infection, or urinary tract infection.
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TABLE 3. Adjusted relative difference in C-reactive protein (mg/liter) per 10-mg/m3 increase in particulate matter of 2.5 mm in
diameter, Multi-Ethnic Study of Atherosclerosis, 2000–2002






Age, gender, racey Nearest monitor 5,634 0.98 0.96, 1.01
All person-level covariatesz Nearest monitor 5,634 0.99 0.96, 1.01
All person-level covariates and site§ Nearest monitor 5,634 0.98 0.96, 1.01
All person-level covariates, site, copollutants, and weather{ Nearest monitor 5,047# 0.97 0.94, 1.01
All person-level covariates and site§ Study site average** 5,572# 0.98 0.96, 1.01
All person-level covariates and site§ Nearest, limited to 9 km 2,831# 0.96 0.92, 1.00
Prior 2 days
Age, gender, racey Nearest monitor 5,606 0.97 0.94, 1.00
All person-level covariatesz Nearest monitor 5,606 0.99 0.96, 1.01
All person-level covariates and site§ Nearest monitor 5,606 0.98 0.95, 1.01
All person-level covariates, site, copollutants, and weather{ Nearest monitor 5,023# 0.97 0.93, 1.01
All person-level covariates and site§ Study site average** 5,498# 0.98 0.95, 1.01
All person-level covariates and site§ Nearest, limited to 9 km 2,803# 0.96 0.91, 1.00
Prior 7 days
Age, gender, racey Nearest monitor 5,510 0.98 0.94, 1.02
All person-level covariatesz Nearest monitor 5,510 1.00 0.96, 1.04
All person-level covariates and site§ Nearest monitor 5,510 0.99 0.95, 1.04
All person-level covariates, site, copollutants, and weather{ Nearest monitor 4,913# 0.99 0.93, 1.04
All person-level covariates and site§ Study site average** 5,187# 1.00 0.95, 1.04
All person-level covariates and site§ Nearest, limited to 9 km 2,237# 0.98 0.91, 1.06
Prior 30 days
Age, gender, racey Nearest monitor 5,294 0.99 0.93, 1.06
All person-level covariatesz Nearest monitor 5,294 1.03 0.98, 1.10
All person-level covariates and site§ Nearest monitor 5,294 1.02 0.95, 1.10
All person-level covariates, site, copollutants, and weather{ Nearest monitor 4,579# 1.02 0.94, 1.12
All person-level covariates and site§ Study site average** 4,307# 1.03 0.96, 1.12
All person-level covariates and site§ Nearest, limited to 9 km 925# 1.09 0.89, 1.34
Prior 60 days
Age, gender, racey Nearest monitor 5,136 0.98 0.91, 1.05
All person-level covariatesz Nearest monitor 5,136 1.04 0.97, 1.11
All person-level covariates and site§ Nearest monitor 5,136 1.02 0.93, 1.11
All person-level covariates, site, copollutants, and weather{ Nearest monitor 4,219# 0.99 0.89, 1.11
All person-level covariates and site§ Study site average** 3,813# 1.01 0.91, 1.13
All person-level covariates and site§ Nearest, limited to 9 km 369# 0.90 0.47, 1.73
* For each exposure, all persons with complete data were included. Sample size varies by exposure measure because of missing data.
yModel variables: age (1 df), gender (1 df), and race/ethnicity (3 df).
zModel variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df), body mass index (1 df), diabetes (2 df), cigarette
status (2 df), secondhand smoke (1 df), physical activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal
antiinflammatory drugs) (1 df), and infections in last 2 weeks (1 df).
§ Model variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df), body mass index (1 df), diabetes (2 df), cigarette
status (2 df), secondhand smoke (1 df), physical activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal
antiinflammatory drugs) (1 df), infections in last 2 weeks (1 df), and study site (5 df).
{Model variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df), body mass index (1 df), diabetes (2 df), cigarette
status (2 df), secondhand smoke (1 df), physical activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal
antiinflammatory drugs) (1 df), infections in last 2 weeks (1 df), study site (5 df), sulfur dioxide (1 df), nitrogen dioxide (1 df), carbon monoxide
(1 df), ozone (1 df), average temperature (1 df), and dew point temperature (1 df).
# Addition of copollutants/weather or study site average or nearest monitor within 9 km resulted in a smaller number of observations because of
missing data.
** Based on the average of all monitors within 40 km of the study site centroid.
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of lung disease), only season revealed statistically signifi-
cant interactions consistently across lags. Associations were
generally negative for the warm season (March–August) and
null or weakly positive for the cool season (September–
February) (relative difference per 10-lg/m3 increase in PM2.5:
0.95 (95 percent confidence interval (CI): 0.92, 0.99) and
1.01 (95 percent CI: 0.97, 1.05) for prior day exposure in
warm and cool seasons, respectively, and 0.92 (95 percent
CI: 0.80, 1.05) and 1.06 (95 percent CI: 0.93, 1.21) for
60-day exposure in warm and cool seasons, respectively).
In analyses with C-reactive protein of greater than or
equal to 3 mg/liter as a dichotomous outcome, weak positive
associations between PM2.5 exposures and C-reactive pro-
tein were observed for some of the models for prior 7-, 30-,
and 60-day means, but confidence intervals were wide and
included the null value (table 4). In most cases, adjustment
for site, copollutants, and weather resulted in estimates even
closer to the null. Associations of PM2.5 exposures with the
odds of C-reactive protein of greater than or equal to 3 mg/
liter appeared to be stronger or present only in participants
without other risk factors for elevated C-reactive protein, but
tests for interaction did not achieve statistical significance
(figure 3). No positive associations between particulate mat-
ter exposures were observed when selected analyses were
repeated using interleukin-6 as the outcome.
DISCUSSION
We found no consistent evidence that recent exposure to
PM2.5 levels is positively associated with C-reactive protein
concentration in a population-based sample. Of the five
exposure measures investigated (prior day, prior 2 days, prior
week, prior 30 days, and prior 60 days), only the 30-day
and 60-day mean exposures showed the expected positive
association in analyses of log C-reactive protein as a contin-
uous outcome (3–4 percent increase per 10-lg/m3 difference
in PM2.5 in models adjusted for person-level covariates). The
mean 7-, 30-, and 60-day exposures were weakly, positively,
and nonsignificantly associated with the odds of C-reactive
protein of greater than or equal to 3 mg/liter after adjust-
ment for person-level covariates (increased odds ranging
from 5 percent to 12 percent depending on the model).
FIGURE 2. Relative differences (with 95% confidence intervals) in C-reactive protein (mg/liter) per 10-lg/m3 increase in particulate matter of
2.5 lm in diameter for different exposure periods in a restricted sample without risk factors for elevated C-reactive protein and in the rest of the
sample, adjusted for person-level covariates, Multi-Ethnic Study of Atherosclerosis, 2000–2002. The ‘‘restricted’’ sample (20%, n ¼ 1,123) are non-
smokers without a history of recent infection or arthritis, in good to excellent health, with normal glucose, and who are not taking antiinflam-
matory medications; ‘‘others’’ are the participants not in the restricted sample. Analyses were adjusted for age, gender, race/ethnicity, general
health status, body mass index, diabetes, cigarette smoking, secondhand smoke, physical activity, arthritis flare, medications, and infections. The
p values for interaction between exposure and sample group (restricted vs. other) were 0.4, 0.7, 0.8, 0.4, and 0.8 for the prior day, prior 2 days, prior
7 days, prior 30 days, and prior 60 days, respectively.
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Associations were of small magnitude and became even
weaker after additional adjustment for site, copollutants,
and weather, and confidence intervals of all estimates
included the null value. Although stratified analyses sug-
gested stronger associations in persons without other risk
factors for elevated C-reactive protein, this heterogeneity
was not statistically significant. We also found no evi-
dence of associations between particulate matter expo-
sures and interleukin-6 (not shown).
Prior evidence regarding the relation between short-term
exposures to particulate matter and C-reactive protein con-
centration is not entirely consistent. In one of the largest
TABLE 4. Odds ratios of C-reactive protein of 3 mg/liter per 10-mg/m3 increase in
particulate matter of 2.5 mm in diameter, Multi-Ethnic Study of Atherosclerosis,
2000–2002
Exposure data and adjustment variables No. Odds ratio 95% confidence interval
Prior day
Age, gender, race* 5,634 0.97 0.92, 1.03
All person-level covariatesy 5,634 0.98 0.92, 1.04
All person-level covariates and sitez 5,634 0.96 0.90, 1.02
All person-level covariates, site,
copollutants, and weather§ 5,047 0.92 0.85, 0.99
Prior 2 days
Age, gender, race* 5,606 0.97 0.91, 1.04
All person-level covariatesy 5,606 0.99 0.93, 1.06
All person-level covariates and sitez 5,606 0.97 0.90, 1.04
All person-level covariates, site,
copollutants, and weather§ 5,023 0.95 0.87, 1.04
Prior 7 days
Age, gender, race* 5,510 1.01 0.93, 1.10
All person-level covariatesy 5,510 1.05 0.96, 1.15
All person-level covariates and sitez 5,510 1.01 0.91, 1.12
All person-level covariates, site,
copollutants, and weather§ 4,913 1.00 0.88, 1.14
Prior 30 days
Age, gender, race* 5,294 1.04 0.91, 1.18
All person-level covariatesy 5,294 1.12 0.98, 1.29
All person-level covariates and sitez 5,294 1.09 0.92, 1.29
All person-level covariates, site,
copollutants, and weather§ 4,579 1.13 0.92, 1.40
Prior 60 days
Age, gender, race* 5,136 1.01 0.87, 1.17
All person-level covariatesy 5,136 1.12 0.96, 1.32
All person-level covariates and sitez 5,136 1.05 0.85, 1.31
All person-level covariates, site,
copollutants, and weather§ 4,219 1.03 0.79, 1.34
* Model variables: age (1 df), gender (1 df), and race/ethnicity (3 df).
yModel variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df),
body mass index (1 df), diabetes (2 df), cigarette status (2 df), secondhand smoke (1 df), physical
activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal anti-
inflammatory drugs) (1 df), and infections in last 2 weeks (1 df).
zModel variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df),
body mass index (1 df), diabetes (2 df), cigarette status (2 df), secondhand smoke (1 df), physical
activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal anti-
inflammatory drugs) (1 df), infections in last 2 weeks (1 df), and study site (5 df).
§ Model variables: age (1 df), gender (1 df), race/ethnicity (3 df), general health status (4 df),
body mass index (1 df), diabetes (2 df), cigarette status (2 df), secondhand smoke (1 df), physical
activity (2 df), arthritis flare in last 2 weeks (1 df), medications (aspirin, lipids, nonsteroidal anti-
inflammatory drugs) (1 df), infections in last 2 weeks (1 df), study site (5 df), sulfur dioxide (1 df),
nitrogen dioxide (1 df), carbon monoxide (1 df), ozone (1 df), average temperature (1 df), and dew
point temperature (1 df).
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studies to date, Peters et al. (19) found that contemporane-
ous and recent (5 prior days) exposures to total suspended
particulates were associated with C-reactive protein con-
centration in a sample of 631 men with two repeated mea-
sures. C-reactive protein increased 0.88 mg/liter for each
26-lg/m3 increase in the previous 5-day average level of total
suspended particulates. Seaton et al. (22) found positive
associations between recent (up to 3-day) city-level expo-
sures to PM10 and C-reactive protein (147 percent increase
in C-reactive protein per 100-lg/m3 increase in PM10) in
a sample of 112 persons with multiple repeated measures
over 18 months, although no associations were observed for
person-level measures of exposure. Pope et al. (23) found
a positive association between recent (up to 3-day) PM2.5
exposure and C-reactive protein in 88 subjects with a mean
of 2.8 repeated measures, but this association disappeared
when one influential subject was removed from the sample.
One prior study has reported increases in interleukin-6 as-
sociated with PM10 exposure during an acute episode of air
pollution in a sample of 30 healthy volunteers, but the mag-
nitude of the increase in PM10 studied (from 40 lg/m
3 to
125 lg/m3) was much greater than the variation observed in
our sample (10).
An advantage of our study over prior work is the large
sample size, as well as the geographic and demographic
diversity of the sample. Although there was limited
within-site spatial variability in PM2.5, at least as reflected
by ambient monitors, our analyses rely more on day-to-day
variability than on between-site or within-site variability.
However, it is possible that the range of values present in
our sample did not allow us to detect important threshold
effects at the higher end of the particulate matter distribu-
tion. In a comparison of the magnitude of PM2.5 exposure
with US Environmental Protection Agency National Ambient
Air Quality Standards, almost half (47 percent) of the sam-
ple had prior day PM2.5 levels that exceeded the annual
standard of 15 lg/m3, although less than 1 percent had prior
day PM2.5 levels that exceeded the 24-hour standard of 65
lg/m3. Two prior studies based on ambient monitoring that
reported an association between exposure to particulate
matter and C-reactive protein may have contrasted more
extreme values by studying an air pollution episode (19)
FIGURE 3. Odds ratios (with 95% confidence intervals) of C-reactive protein of3 mg/liter per 10-lg/m3 increase in particulate matter of2.5 lm
in diameter for different exposure periods in a restricted sample without risk factors for elevated C-reactive protein and in the rest of the sample,
adjusted for person-level covariates, Multi-Ethnic Study of Atherosclerosis, 2000–2002. The ‘‘restricted’’ sample (20%, n¼ 1,123) are nonsmokers
without a history of recent infection or arthritis, in good to excellent health, with normal glucose, and who are not taking antiinflammatory
medications; ‘‘others’’ are the participants not in the restricted sample. Analyses were adjusted for age, gender, race/ethnicity, general health
status, body mass index, diabetes, cigarette smoking, secondhand smoke, physical activity, arthritis flare, medications, and infections. p values
for interaction between exposure and sample group (restricted vs. other) were 0.5, 0.5, 0.5, 0.3, and 0.6 for the prior day, prior 2 days, prior 7 days,
prior 30 days, and prior 60 days, respectively.
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or by purposely sampling high and low air pollution days
(23), although at least one study has reported associations
even at relatively low levels of PM2.5 exposures (34).
We relied on the existing ambient air-monitoring network
to characterize exposures. Outdoor concentrations have
been shown to be reasonable proxies for personal exposure
to particles of outdoor origin (35, 36). Indoor exposures
(such as those from passive smoking and wood-burning
stoves and fireplaces) are important contributors to personal
particle exposure and are not captured by the outdoor mea-
surements. However, in order to be confounders of the effects
we were interested in estimating, these indoor exposures
would have to be associated with ambient levels on the
day of the clinic examination, which is unlikely. Moreover,
our results were adjusted for passive smoking, which is
likely to be the major contributor to indoor exposures in
the populations we studied.
The existing literature has characterized personal expo-
sures based on monitor measurements averaged over very
large areas: within a county (37), within a metropolitan area
(38, 39), or within a city (40). Single ‘‘representative’’ mon-
itors located in the center of a city have also been used (22,
41). We used data from the monitors closest to each partic-
ipant’s residence. Thirty-eight percent of study participants
were not employed at the time of the survey (retired and not
working, unemployed, or homemakers). In addition, over
75 percent of our participants reported spending 60 percent
of their time either in their home or within 1 mile (1.6 km) of
their home. This suggests that assignment of exposure based
on place of residence is reasonable. We tested the sensitivity
of our results to alternate ways of estimating exposure and
found similar results when analyses were restricted to par-
ticipants with monitors within 9 km of their home and when
the exposure measure was based on the average of all avail-
able measurements within the study area. The high within-
site correlation of monitor PM2.5 measures suggests that the
results are unlikely to be highly sensitive to alternate meth-
ods, such as averaging over the specific areas within which
participants are likely to move in the course of a usual day.
The results were also robust to alternative interpolation
methods.
There is little a priori knowledge on which to base hy-
potheses regarding the relevant lags expected between ex-
posure to particulate matter and effects on inflammatory
markers. Circulating C-reactive protein has a plasma half-
life of only 19 hours and can be upregulated rapidly, within
hours, during an acute-phase response (42). Human and
animal experimental studies have found that an inflamma-
tory response occurs 6–36 hours after exposure to particles
(13–16). This evidence suggests that short-term lags are
likely to be especially relevant for C-reactive protein. Pope
et al. (23) found that concurrently measured PM2.5 was more
strongly associated with C-reactive protein than were mea-
sures lagged 1 or 2 days, although an effect almost compa-
rable with the concurrent day was observed for the average
of the 3 days prior. Peters et al. (19) found that levels of
C-reactive protein were positively associated with levels of
total suspended particulates on the day of the examination.
However, similar or slightly stronger associations were ob-
served for total suspended particulates measured on the
prior day and for the mean of the prior 5 days, suggesting
longer-term cumulative effects. In our analyses, the only
weakly positive (albeit not statistically significant) associa-
tions were observed for the longer lags. Zanobetti et al.
(43) recently reported a positive association between prior
60-day PM2.5 exposure and C-reactive protein concentration
in a large population sample: C-reactive protein increased 7.7
percent per 10-lg/m3 increase in PM2.5 (95 percent CI: 0.96,
14.96). Given the relatively short half-life of C-reactive pro-
tein, it is difficult to reconcile the presence of long-term
exposure effects with the absence of effects for shorter lags.
An alternative explanation for associations with longer-term
exposure periods is that the averaging process reduces mea-
surement error and hence increases the ability to detect
associations.
Similarly to some prior studies of air pollution exposures
and inflammatory markers (20, 21, 41), our analyses are
based on a single measure of C-reactive protein on each
person. Therefore, inferences are based on between-person
as opposed to within-person comparisons. This raises the
possibility that associations (or the lack thereof) could result
from confounding by individual-level characteristics. Our
analyses controlled for a large set of variables associated
with C-reactive protein levels. Analyses of residuals re-
vealed no evidence of seasonal patterns or residual autocor-
relation in adjusted models. It is therefore unlikely that our
null findings are the result of individual-level confounding.
Studies of repeated measures, however, which allow infer-
ences to be drawn by within-person comparisons, do have
greater power for detecting associations with exposures that
change over time while holding time-independent individual-
level factors constant (44). Repeated-measures analyses based
on the MESA cohort will be possible as additional follow-up
becomes available.
Measurement error in our exposure estimates may have
biased results toward the null. More detailed assessment of
personal exposures (involving activity diaries and additional
monitoring both indoors and outdoors) currently planned
for the MESA cohort will allow much more precise mea-
surement of personal exposures. It is also plausible that
improved measurement of specific components of PM2.5
(such as ultrafine particles or transition metals) may enhance
our ability to detect effects on systemic inflammation (9). In
any case, our results make it unlikely that a systemic in-
flammatory response explains the short-term effects of re-
cent exposures observed in time-series analyses, which also
rely exclusively on monitor data. Inconsistent results regard-
ing the relation between ambient particulate matter mass
and markers of systemic inflammation, plus persistent ques-
tions on the extent to which inflammation is a risk factor,
risk marker, or simply a correlate of atherosclerosis (45), sug-
gest that other mechanistic pathways linking particulate matter
exposures to cardiovascular events need to be explored.
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